Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 2:2018:9475919.
doi: 10.1155/2018/9475919. eCollection 2018.

Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy

Affiliations

Effect of Japanese Kampo Medicine Therapy for Menopausal Symptoms after Treatment of Gynecological Malignancy

Akihiko Yoshimura et al. Obstet Gynecol Int. .

Abstract

Loss of ovarian function by the treatment for gynecological malignancy results in a drastic decrease of estrogen causing physical and mental symptoms. The purpose of this study is to evaluate the effect of Japanese Kampo Kamikihito (KKT) and Kamishoyosan (KSS) on menopausal symptoms in gynecological cancer patients. Patients who had menopausal symptoms after gynecologic malignancy treatment were enrolled and randomly divided into a KKT or a KSS group. Kupperman Menopausal Index (KI) questionnaires were obtained before tumor treatment, at baseline, and at 4 and 8 weeks. Changes in KI scores and severity of each symptom were evaluated. A total of 33 patients were enrolled: 18 in the KKT group and 15 in the KSS group. The KI scores significantly decreased at 4 and 8 weeks compared with baseline in both groups. Although no significant difference was found in change in KI scores between the KKT and KSS groups, efficacy showed some differences. Both KKT and KSS were effective for insomnia, vertigo, and palpitation. KSS was also effective for vasomotor symptoms and arthralgia/myalgia. In conclusion, both KKT and KSS were effective for menopausal symptoms in patients after gynecological tumor treatment. Tailor-made Kampo therapy may contribute to improve patients' physical and mental symptoms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient flow. Patients who had general malaise after treatment of gynecological malignant tumor with a total score of 21 or over on the KI were randomly assigned to KKT or KSS. A Kupperman Menopausal Index (KI) questionnaire survey was conducted on subjective symptoms before tumor treatment, at baseline (before Kampo treatment), at 4 weeks, and at 8 weeks. Changes in KI score were evaluated in both groups. KI: Kupperman Menopausal Index; KKT: Kamikihito; KSS: Kamishoyosan; Kampo: Japanese Kampo medicine.
Figure 2
Figure 2
KI scores at four time points: (a) the KKT group and (b) the KSS group. The KI scores significantly elevated after initial tumor therapy (baseline) and significantly decreased at 4 and 8 weeks of study drug treatment compared with baseline in both groups. KKT: Kamikihito; KSS: Kamishoyosan.

References

    1. Singh P., Oehler M. K. Hormone replacement after gynaecological cancer. Maturitas. 2010;65(3):190–197. doi: 10.1016/j.maturitas.2009.11.017. - DOI - PubMed
    1. Li D., Ding C. Y., Qiu L. H. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis. Gynecologic Oncology. 2015;139(2):355–362. doi: 10.1016/j.ygyno.2015.07.109. - DOI - PubMed
    1. Ayhan A., Taskiran C., Simsek S., Sever A. Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors? International Journal of Gynecological Cancer. 2006;16(2):805–808. doi: 10.1111/j.1525-1438.2006.00526.x. - DOI - PubMed
    1. Yu F., Takahashi T., Moriya J., et al. Traditional Chinese medicine and Kampo: a review from the distant past for the future. Journal of International Medical Research. 2006;34(3):231–239. doi: 10.1177/147323000603400301. - DOI - PubMed
    1. Yakubo S., Ito M., Ueda Y., et al. Pattern classification in Kampo medicine. Evidence-Based Complementary and Alternative Medicine (eCAM) 2014;2014:5. doi: 10.1155/2014/535146.535146 - DOI - PMC - PubMed

LinkOut - more resources